Abstract
We report 16 cases of neonatal vascular thrombosis treated with the same protocol for recombinant tissue-type plasminogen activator infusion. Flow restoration was complete in seven patients, partial in seven, and absent in two. Safety was satisfactory provided contraindications were respected.
MeSH terms
-
Fibrinolytic Agents / therapeutic use
-
Heparin / therapeutic use
-
Humans
-
Infant
-
Infant, Newborn
-
Plasminogen Activators / adverse effects
-
Plasminogen Activators / therapeutic use*
-
Recombinant Proteins
-
Retrospective Studies
-
Risk Factors
-
Thrombosis / drug therapy*
-
Thrombosis / mortality
-
Tissue Plasminogen Activator / adverse effects
-
Tissue Plasminogen Activator / therapeutic use*
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
Recombinant Proteins
-
Heparin
-
Plasminogen Activators
-
Tissue Plasminogen Activator